Extensions for Using Data Elements from FHIR STU3 in FHIR R4B
0.1.0 - STU International flag

Extensions for Using Data Elements from FHIR STU3 in FHIR R4B - Downloaded Version null See the Directory of published versions

ValueSet: R3V3SubstanceAdminSubstitutionForR4B

Official URL: http://hl7.org/fhir/uv/xver/ValueSet/R3-v3-substanceAdminSubstitution-for-R4B Version: 0.1.0
Standards status: Trial-use Maturity Level: 0 Computable Name: R3V3SubstanceAdminSubstitutionForR4B

This cross-version ValueSet represents content from http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2016-11-11 for use in FHIR R4B.

This value set is part of the cross-version definitions generated to enable use of the value set http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2016-11-11 as defined in FHIR STU3 in FHIR R4B.

The source value set is bound to the following FHIR STU3 elements:

Across FHIR versions, the value set has been mapped as:

  • http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2016-11-11
  • http://terminology.hl7.org/ValueSet/v3-substanceAdminSubstitution|2018-08-12

Note that all concepts are included in this cross-version definition because no concepts have compatible representations

Following are the generation technical comments: All concepts in the comparison are listed as identical. The source and target value sets have the same number of active concepts (9). FHIR ValueSet http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2016-11-11, defined in FHIR STU3 does not have any mapping to FHIR R4B

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

  • Include these codes as defined in http://hl7.org/fhir/v3/substanceAdminSubstitution version 📍2016-11-11
    CodeDisplayDefinition
    BCbrand compositionDescription:


    Substitution occurred or is permitted between equivalent Brands but not Generics


    Examples:



    Zestril for Prinivil
    Coumadin for Jantoven
    EequivalentDescription: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.
    ECequivalent compositionDescription:


    Substitution occurred or is permitted with another product that is a:


    pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
    pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration


    Examples:




    Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate

    Pharmaceutical equivalent: Lisonpril for Zestril
    FformularyDescription: This substitution was performed or is permitted based on formulary guidelines.
    Ggeneric compositionDescription: Substitution occurred or is permitted between equivalent Generics but not Brands


    Examples:



    Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
    NnoneNo substitution occurred or is permitted.
    TBtherapeutic brandDescription: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics
    >
    Examples:



    Zantac for Tagamet
    TEtherapeutic alternativeDescription: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.


    Examples:



    ranitidine for Tagamet
    TGtherapeutic genericDescription: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands
    >
    Examples:



    Ranitidine for cimetidine
    _ActSubstanceAdminSubstitutionCodeActSubstanceAdminSubstitutionCodeDescription: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.

 

Expansion

This value set expansion contains 10 concepts.

SystemVersionCodeDisplayDefinitionJSONXML
http://hl7.org/fhir/v3/substanceAdminSubstitution2016-11-11  BCbrand composition

Description:

                    Substitution occurred or is permitted between equivalent Brands but not Generics

                    
                       Examples: 
                    

                    
                       Zestril  for Prinivil
                       Coumadin for Jantoven
http://hl7.org/fhir/v3/substanceAdminSubstitution2016-11-11  Eequivalent

Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.

http://hl7.org/fhir/v3/substanceAdminSubstitution2016-11-11  ECequivalent composition

Description:

                    Substitution occurred or is permitted with another product that is a:

                    
                       pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
                       pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration
                    
                    
                       Examples: 
                    

                    
                       
                          Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
                       
                          Pharmaceutical equivalent: Lisonpril for Zestril
http://hl7.org/fhir/v3/substanceAdminSubstitution2016-11-11  Fformulary

Description: This substitution was performed or is permitted based on formulary guidelines.

http://hl7.org/fhir/v3/substanceAdminSubstitution2016-11-11  Ggeneric composition

Description: Substitution occurred or is permitted between equivalent Generics but not Brands

                       Examples: 
                    

                    
                       Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
http://hl7.org/fhir/v3/substanceAdminSubstitution2016-11-11  Nnone

No substitution occurred or is permitted.

http://hl7.org/fhir/v3/substanceAdminSubstitution2016-11-11  TBtherapeutic brand

Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics

                       Examples: 
                    

                    
                       Zantac for Tagamet
http://hl7.org/fhir/v3/substanceAdminSubstitution2016-11-11  TEtherapeutic alternative

Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.

                       Examples: 
                    

                    
                       ranitidine for Tagamet
http://hl7.org/fhir/v3/substanceAdminSubstitution2016-11-11  TGtherapeutic generic

Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands

                       Examples: 
                    

                    
                       Ranitidine  for cimetidine
http://hl7.org/fhir/v3/substanceAdminSubstitution2016-11-11  _ActSubstanceAdminSubstitutionCodeActSubstanceAdminSubstitutionCode

Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.


Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code